Sažetak
Uvod: Ekstramedularna lokalizacija plazmocitoma u regiji glave i vrata čini manje od 1% tumora te regije. Primarna solitarna lokalizacija u limfnom čvoru, bez proliferacije plazmocita na bilo kojoj drugoj lokalizaciji, kao jedina manifestacija plazmocitoma, izuzetno je retka. Do sada je referisano manje od 50 slučajeva.
Prikaz slučaja: Muškarac, star 58 godina, zbog uvećane bezbolne žlezde na vratu, bez temperature, preznojavanja i gubitka u težini, obratio se lekaru. Tretiran je antibioticima širokog spektra u trajanju od 10 dana, ali nije bilo promene. Urađena kompletna krvna slika je imala uredan nalaz. Biohumoralni zapaljenski sindrom je bio negativan, a kompletna biohemija u referentnom opsegu. Urađen je eho vrata i registrovana jedna limfna žlezda promera 30 mm x 15 mm. Pacijent je upućen maksilofacijalnom hirurgu, žlezda je u celosti ekstirpirana i poslata na histopatološku analizu. Dobijen je sledeći patohistološki nalaz (PH): difuzna infiltracija plazmocitoidnim tumorskim ćelijama visoke pozitivnosti za: OCT2, BOB1, CD38, MUM1, lambda, CD31,VIM i CD79 alfa; negativne na kapa; Ki67 pozitivne u 30%. Zaključak patohistološkog nalaza je bio: plazmocitom lambda pozitivan. Biopsija koštane srži (BK) dala je sledeći patohistološki nalaz: plazmociti 4%. Snimanjem multislajsnim skenerom (MSCT) grudnog koša, abdomena i male karlice dobijen je uredan nalaz. Radiografski pregled skeleta je bio uredan. M komponenta u serumu i urinu je bila negativna. Virusologija je pokazala HBsAg pozitivnost, dok su HCV i HIV bili negativni. Indikovana je lokalna zračna terapija uz aktivno lečenje antiviroticima.
Zaključak: Svaka limfadenopatija zahteva ozbiljan i detaljan pristup kliničara. Da li je HBV infekcija bila okidač za nastanak plazmocitoma, ostaje za razmatranje.
Ključne reči
Array
Array
Reference
Guedes A, Becker RG, Teixeira LEM. Multiple Myeloma (Part 1) – Update on epidemiology, diagnostic criteria, systemic treatment and prognosis. Rev Bras Ortop (Sao Paulo). 2023 Jun 29;58(3):361-7. doi: 10.1055/s-0043-1770149.
Silva ROP, Brandão KMA, Pinto PVM, Faria RMD, Clementino NCD, Silva CMF, et al. Mieloma múltiplo: características clínicas e laboratoriais ao diagnóstico e estudo prognóstico. Rev Bras Hematol Hemoter. 2009;31(02):63-8. doi: 10.1590/S1516-84842009005000013.
Ponte FM, Garcia Filho RJ, Hadler MB, Korukian M, Ishihara HY. Avaliação do tratamento ortopédico no mieloma múltiplo. Rev Bras Ortop. 2002;37(05):162-70.
Rajkumar SV. Multiple myeloma: 2020 update on diagnosis, risk-stratification and management. Am J Hematol. 2020 May;95(5):548-67. doi: 10.1002/ajh.25791.
American Cancer Society [Internet]. Atlanta American Cancer Society; c2020. About multiple myeloma [Accessed: 12. 3. 2020.]. Available from: https://www.cancer.org/cancer/multiple-myeloma/about/what-is-multiple-myeloma.html.
Sucro LV, Silva JCML, Gehlen GW, Eldin JFS, Amaral GA, Santana MAP. Mieloma múltiplo: diagnóstico e tratamento. Rev Med Minas Gerais 2009;19(01):58-62.
Guedes A, Becker RG, Teixeira LEM. Multiple Myeloma (Part 2) - Update on the approach to bone disease. Rev Bras Ortop (Sao Paulo). 2023 Jun 29;58(3):368-7. doi: 10.1055/s-0043-1770150.
Batsakis JG, Medeiros JL, Luna MA, El-Naggar AK. Plasma cell dyscrasias and the head and neck. Ann Diagn Pathol. 2002 Apr;6(2):129-40. doi: 10.1053/adpa.2002.33458.
Menke DM, Horny HP, Griesser H, Tiemann M, Katzmann JA, Kaiserling E, et al. Primary lymph node plasmacytomas (plasmacytic lymphomas). Am J Clin Pathol. 2001 Jan;115(1):119-26. doi: 10.1309/L2GR-PCFM-G4A3-GHDW.
Lim YH, Park SK, Oh HS, Choi JH, Ahn MJ, Lee YY, et al. A case of primary plasmacytoma of lymph nodes. Korean J Intern Med. 2005 Jun;20(2):183-6. doi: 10.3904/kjim.2005.20.2.183.
Woodruff RK, Whittle JM, Malpas JS. Solitary plasmacytoma. I: Extramedullary soft tissue plasmacytoma. Cancer. 1979 Jun;43(6):2340-3. doi: 10.1002/1097-0142(197906)43:6<2340:aid-cncr2820430625>3.0.co;2-m.
Pantelidou D, Tsatalas C, Margaritis D, Karayiannakis AJ, Kaloutsi V, Spanoudakis E, et al. Extramedullary plasmacytoma: report of two cases with uncommon presentation. Ann Hematol. 2005 Mar;84(3):188-91. doi: 10.1007/s00277-004-0854-y.
Alfar R, Al-Shatti M, Alomari Z, Bater R, Rahal R, Abdel-Razeq R, et al. Primary extra-medullary plasmacytoma with lymph node involvement, lymphoma mimicry: a case report and review of the literature. Med Case Rep. 2022;8(6):230. doi: 10.36648/2471-8041.8.6.230.
Gerry D, Lentsch EJ. Epidemiologic evidence of superior outcomes for extramedullary plasmacytoma of the head and neck. Otolaryngol Head Neck Surg. 2013 Jun;148(6):974-81. doi: 10.1177/0194599813481334.
Alexiou C, Kau RJ, Dietzfelbinger H, Kremer M, Spiess JC, Schratzenstaller B, et al. Extramedullary plasmacytoma: tumor occurrence and therapeutic concepts. Cancer. 1999 Jun 1;85(11):2305-14. doi: 10.1002/(SICI)1097-0142(19990601)85:11<2305::AID-CNCR2>3.0.CO;2-3.
Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine (Baltimore). 1976 May;55(3):217-38. doi: 10.1097/00005792-197605000-00002.
Galieni P, Cavo M, Pulsoni A, Avvisati G, Bigazzi C, Neri S, et al. Clinical outcome of extramedullary plasmacytoma. Haematologica. 2000 Jan;85(1):47-51.
Soutar R, Lucraft H, Jackson G, Reece A, Bird J, Low E, et al; Guidelines Working Group of the UK Myeloma Forum; British Committee for Standards in Haematology; British Society for Haematology. Guidelines on the diagnosis and management of solitary plasmacytoma of bone and solitary extramedullary plasmacytoma. Br J Haematol. 2004 Mar;124(6):717-26. doi: 10.1111/j.1365-2141.2004.04834.x.